Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneca (AZN) and Allergan (AGN) Complete Licensing Agreement for MEDI2070 Antibody Candidate in Mid-Stage Development for Crohn's Disease and Ulcerative Colitis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Nov 17, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Licensing Agreement, Medi2070, Monoclonal Antibody, Product Candidate, Crohn's Disease, Ulcerative Colitis